Hematology in 10 min: Iron deficiency anemia and anemia of chronic disease

preview_player
Показать описание
Iron deficiency anemia is the most common anemia worldwide.
The essential parts from the large subject were extracted and explained in a simple way for medical students and other health care professionals.

*Error*
At 8:45, I mistakenly said 'Thrombosis' instead of 'Thrombocytosis'.
I am sorry for the inconvenience.

Claremont, California
Рекомендации по теме
Комментарии
Автор

2/1/2023
The US Food and Drug Administration (FDA) has approved Jesduvroq (daprodustat), an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the once-a-day treatment of anaemia due to chronic kidney disease (CKD) in adults who have been receiving dialysis for at least four months. Jesduvroq is the first innovative medicine for anaemia treatment in over 30 years and the only HIF-PHI approved in the US, providing a new oral, convenient option for patients in the US with anaemia of CKD on dialysis.

stanleykim